Category: Pharma Industry News
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Voydeya approved in EU for enhanced treatment of PNH with residual haemolytic anaemia
Voydeya (danicopan), a first-in-class oral Factor D inhibitor from Alexion, AstraZeneca Rare Disease, has received approval from the European Commission as an add-on treatment to ... Read More
Dr. Reddy’s Laboratories announces voluntary recall of Sapropterin Dihydrochloride due to potency concerns
Dr. Reddy's Laboratories Ltd., a prominent pharmaceutical company listed on multiple stock exchanges including BSE: 500124 and NYSE: RDY, has initiated a voluntary recall of ... Read More
Alcanza Clinical Research acquires FDI Clinical Research to enhance patient representation in clinical trials
Alcanza Clinical Research, a prominent investigator site network focused on inclusive clinical trials, has announced its acquisition of FDI Clinical Research, a comprehensive multi-specialty research ... Read More
Zydus Lifesciences launches Mirabegron Extended-Release Tablets in US market
Zydus Lifesciences Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the US market, following the final approval from the United States ... Read More
BioArctic and Eisai team up on Alzheimer’s disease candidate BAN2802
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) has entered into a new research evaluation agreement with Eisai Co., Ltd. The collaboration focuses on BAN2802, a ... Read More
Lilly announces significant results in SURMOUNT-OSA trials of tirzepatide in OSA
Eli Lilly and Company (NYSE: LLY) has released positive topline results from the phase 3 SURMOUNT-OSA clinical trials, demonstrating that tirzepatide injection significantly reduces the ... Read More
Kiosk Operators expands in pharmaceutical kiosk space with Wellmation acquisition
Kiosk Operators LLC, a prominent provider of kiosk and locker solutions, has recently acquired Wellmation, a leader in pharmaceutical kiosk technology. This strategic move incorporates ... Read More
BiVictriX Therapeutics receives FDA orphan drug designation for BVX001 in AML
BiVictriX Therapeutics plc (AIM: BVX), a prominent UK-based biotechnology firm, has reached a pivotal regulatory milestone as the US Food and Drug Administration (FDA) has ... Read More
Novartis announces promising long-term data on Kesimpta for relapsing multiple sclerosis
In a significant revelation, Novartis Pharmaceuticals Corporation has announced the latest findings from the ALITHIOS open-label extension study. The data underscores the sustained efficacy of ... Read More
GSK reveals significant Shingrix vaccine efficacy in ZOSTER-049 trial
GSK plc announced the results of the ZOSTER-049 phase III long-term follow-up trial, showcasing that the Shingrix (Recombinant Zoster Vaccine or RZV) maintains high efficacy ... Read More